NCT00391053: Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly |
|
|
| Completed | 3 | 3851 | US | High-Dose Inactivated, Split-Virion Influenza Vaccine, Fluzone® High-Dose, Inactivated, Split-Virion Influenza Vaccine, Fluzone® 2006-2007 formulation | Sanofi Pasteur, a Sanofi Company | Orthomyxoviridae Infection, Influenza, Myxovirus Infection | 07/07 | 02/08 | | |
NCT00976027: Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and Older |
|
|
| Terminated | 3 | 9172 | US | Trivalent inactivated influenza vaccine High Dose, Fluzone® High Dose, Trivalent inactivated influenza vaccine, Fluzone® | Sanofi | Influenza | 05/11 | 04/12 | | |
